Related Experiment Video
Updated: Aug 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Molecular mechanism of the interaction between MDM2 and p53
Oliver Schon1, Assaf Friedler, Mark Bycroft
1Chemical Laboratory and Cambridge Centre for Protein Engineering, Cambridge University, MRC Centre, UK.
Abstract:
We have investigated the kinetic and thermodynamic basis of the p53-MDM2 interaction using a set of peptides based on residues 15-29 of p53. Wild-type p53 peptide bound MDM2 with a dissociation constant of 580nM. Phosphorylation of S15 and S20 did not affect binding, but T18 phosphorylation weakened binding tenfold, indicating that phosphorylation of only T18 is responsible for abrogating p53-MDM2 binding. Truncation to residues 17-26 increased affinity 13-fold, but further truncation to 19-26 abolished binding. NMR studies of the binding of the p53-derived peptides revealed global conformational changes of the overall structure of MDM2, stretching far beyond the binding cleft, indicating significant changes in the domain dynamics of MDM2 upon ligand binding.
Insights
The p53-MDM2 interaction is crucial for cell cycle regulation. T18 phosphorylation on p53 peptides abrogates binding to MDM2, while other modifications have minimal effects, revealing key insights into this vital protein complex.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- The p53-MDM2 interaction is a critical regulator of the p53 tumor suppressor protein.
- Dysregulation of this interaction is implicated in various cancers.
- Understanding the molecular basis of this interaction is essential for therapeutic development.
Purpose of the Study:
- To investigate the kinetic and thermodynamic factors governing the p53-MDM2 interaction.
- To determine the impact of specific p53 post-translational modifications on binding affinity.
- To elucidate the structural consequences of p53 peptide binding on MDM2.
Main Methods:
- Peptide synthesis based on p53 residues 15-29.
- Biochemical binding assays to determine dissociation constants (Kd).
- Nuclear Magnetic Resonance (NMR) spectroscopy to study structural changes in MDM2.
Main Results:
- Wild-type p53 peptide bound MDM2 with a Kd of 580 nM.
- Phosphorylation at T18 significantly weakened p53-MDM2 binding (tenfold), abrogating the interaction.
- Truncation studies revealed that residues 17-26 are critical for high-affinity binding.
- NMR studies showed global conformational changes in MDM2 upon peptide binding, extending beyond the active site.
Conclusions:
- Phosphorylation at threonine 18 (T18) is the primary modification responsible for disrupting the p53-MDM2 interaction.
- Specific peptide sequences and structural elements within p53 are crucial for high-affinity MDM2 binding.
- Ligand binding induces significant allosteric conformational changes in MDM2, impacting its overall domain dynamics.
Related Concept Videos
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

